K Number
K051115
Device Name
SENTINEL IRON LIQUID
Manufacturer
Date Cleared
2005-08-25

(115 days)

Product Code
Regulation Number
862.1410
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
The Sentinel Iron Liquid is a direct colorimetric in vitro diagnostic assay for the quantitative determination of Iron without deproteinization in human serum and plasma (heparin salts, only). Iron (non-heme) measurements are used in the diagnosis and treatment of diseases such as iron deficiency anemia, hemochromatosis (a disease associated with widespread deposit in the tissues of two iron-containing pigments, hemosiderin and hemofuscin, and characterized by pigmentation of the skin), and chronic renal disease.
Device Description
The Iron Liquid described in this 510(k) submission is composed of reagents and standard, packaged and distributed in the same kit. The device is intended to be sold as an in vitro test for professional use. The Iron Liquid is a direct colorimetric in vitro diagnostic assay for the quantitative determination of iron without deproteinization in human serum and plasma (heparin salt, only). In a pH 4.0 buffer system, iron is released from transferin to which it is bound, and then quantitatively reduced to a ferrous state. The iron forms with Ferene-S a stable colored complex of which the color intensity is proportional to the amount of iron in the sample. Particular reaction conditions and a specific masking agent eliminate the interference from copper.
More Information

Not Found

No
The summary describes a direct colorimetric in vitro diagnostic assay based on chemical reactions and color intensity measurement, with no mention of AI or ML technologies.

No
The device is an in vitro diagnostic assay used for the quantitative determination of Iron in human serum and plasma, which aids in diagnosis and treatment monitoring, but it does not directly treat or provide therapy to a patient.

Yes
The "Intended Use / Indications for Use" section explicitly states that the device is "a direct colorimetric in vitro diagnostic assay for the quantitative determination of Iron" and that "Iron (non-heme) measurements are used in the diagnosis and treatment of diseases".

No

The device description explicitly states it is composed of "reagents and standard, packaged and distributed in the same kit," indicating it is a physical in vitro diagnostic assay kit, not software.

Yes, this device is an IVD (In Vitro Diagnostic).

Here's why:

  • Intended Use/Indications for Use: The description explicitly states it is an "in vitro diagnostic assay" and is used for the "quantitative determination of Iron... in human serum and plasma". It also lists specific diseases it is used in the diagnosis and treatment of, which are conditions diagnosed through laboratory testing of biological samples.
  • Device Description: The description reiterates that the device is intended to be sold as an "in vitro test for professional use". It also describes the reagents and standard included in the kit, which are typical components of an IVD.
  • Overall Context: The entire document is structured like a submission for regulatory review of an IVD, including sections on intended use, device description, performance studies, and predicate devices.

The presence of the phrase "in vitro diagnostic assay" in both the intended use and device description is the most direct confirmation.

N/A

Intended Use / Indications for Use

The Sentinel Iron Liquid is a direct colorimetric in vitro diagnostic assay for the quantitative determination of Iron without deproteinization in human serum and plasma (heparin salts, only).

Iron (non-heme) measurements are used in the diagnosis and treatment of diseases such as iron deficiency anemia, hemochromatosis (a disease associated with widespread deposit in the tissues of two iron-containing pigments, hemosiderin and hemofuscin, and characterized by pigmentation of the skin), and chronic renal disease.

Product codes

CFM, JIY

Device Description

The Iron Liquid described in this 510(k) submission is composed of reagents and standard, packaged and distributed in the same kit. The device is intended to be sold as an in vitro test for professional use.

The Iron Liquid is a direct colorimetric in vitro diagnostic assay for the quantitative determination of iron without deproteinization in human serum and plasma (heparin salt, only). In a pH 4.0 buffer system, iron is released from transferin to which it is bound, and then quantitatively reduced to a ferrous state. The iron forms with Ferene-S a stable colored complex of which the color intensity is proportional to the amount of iron in the sample. Particular reaction conditions and a specific masking agent eliminate the interference from copper.

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Not Found

Anatomical Site

Not Found

Indicated Patient Age Range

Not Found

Intended User / Care Setting

Professional use / Clinical Chemistry

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)

Performance evaluations included sensitivity, intra- and inter-assay precision and method comparison.

Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)

Not Found

Predicate Device(s)

K972363

Reference Device(s)

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information

Not Found

§ 862.1410 Iron (non-heme) test system.

(a)
Identification. An iron (non-heme) test system is a device intended to measure iron (non-heme) in serum and plasma. Iron (non-heme) measurements are used in the diagnosis and treatment of diseases such as iron deficiency anemia, hemochromatosis (a disease associated with widespread deposit in the tissues of two iron-containing pigments, hemosiderin and hemofuscin, and characterized by pigmentation of the skin), and chronic renal disease.(b)
Classification. Class I (general controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 862.9.

0

Image /page/0/Picture/0 description: The image shows the logo for Sentinel Diagnostics. The word "SENTINEL" is written in large, bold, black letters. Below it, the word "DIAGNOSTICS" is written in smaller, thinner letters.

AUG 2 5 2005

510k Summary Sentinel Iron Liquid

Image /page/0/Picture/3 description: The image shows the text "K Number:" followed by the handwritten text "KOS115". The text is written in black ink on a white background. The text is likely a label or identifier for a document or item.

  1. Submitter's information: Mr. Ugo De Luca Managing Director Sentinel CH Srl Via Principe Eugenio 20155 Milan, Italy

Tel.: +39 02 345514 1 Fax: +39 02 345514 64 e-mail: sentinel@sentinel.it

  • Mr. Davide Spada 2. Contact person: Application Specialist Sentinel CH Srl Via Principe Eugenio 20155 Milan, Italy Tel.: +39 02 345514 1 Fax: +39 02 345514 64 e-mail: spada@sentinel.it
    1. Date summary prepared: 21 August 2005

4. Device name and classification

The Sentinel Iron Liquid described in this 510(k) consists of reagents and standard, packaged and distributed in one kit. The device is intended to be sold as an in-vitro test for professional use.

Product name and classification information are provided in Table 4.1 below.

Trade/Device NameRegulation NumberRegulation nameClassification panelRegulatory classProduct Code
Iron Liquid21 CFR 862.1410Direct Colorimetric, IronClinical ChemistryICFM

Device names and classification of Iron Liquid Table 4.1

Device description 5.

The Iron Liquid described in this 510(k) submission is composed of reagents and standard, packaged and distributed in the same kit. The device is intended to be sold as an in vitro test for professional use.

The Iron Liquid is a direct colorimetric in vitro diagnostic assay for the quantitative determination of iron without deproteinization in human serum and plasma (heparin salt, only). In a pH 4.0 buffer system, iron is released from transferin to which it is bound, and then quantitatively reduced to a ferrous state. The iron forms with Ferene-S a stable colored complex of which the color intensity is proportional to the amount of iron in the sample. Particular reaction conditions and a specific masking agent eliminate the interference from copper.

Sentinel Iron Liquid

Image /page/0/Picture/20 description: The image shows the logo for Sentinel Diagnostics. The logo consists of the word "SENTINEL" in large, bold letters, with the word "DIAGNOSTICS" in smaller letters underneath. To the right of the text is a black graphic that resembles a mountain range or a series of peaks.

1

Image /page/1/Picture/0 description: The image shows the logo for Sentinel Diagnostics. The word "SENTINEL" is in large, bold, sans-serif font on the top line. Below that, in a smaller, lighter font, is the word "DIAGNOSTICS."

Intended Use 6.

The Sentinel Iron Liguid is a direct colorimetric in vitro diagnostic assay for the quantitative determination of Iron without deproteinization in human serum and plasma (heparin salts, only).

Iron (non-heme) measurements are used in the diagnosis and treatment of diseases such as iron deficiency anemia, hemochromatosis (a disease associated with widespread deposit in the tissues of two iron-containing pigments, hemosiderin and hemofuscin, and characterized by pigmentation of the skin), and chronic renal disease, CFR 862.1410

Comparison with Predicate Devices 7.

Table 7.1 lists the predicate device for the Sentinel product included in this submission, and provides information on the regulatory status of the predicate device, including the 510(k) number.

Table 7.1 Predicate device for Sentinel UIBC Liquid Diagnostic Assay
----------------------------------------------------------------------

| Sentinel Trade
Device Name | Predicate Device
Name | Predicate Device
Manufacturer | Predicate
device (k) | FDA clear-
ance date |
|-------------------------------|--------------------------|------------------------------------------|-------------------------|-------------------------|
| Iron Liquid | IL Test Iron | Instrumentation
Laboratory
Company | K972363 | 15 Aug 1997 |

Table 7.2 below report a comparison of the Sentinel UIBC Liquid with the Predicate Device Roche UIBC. No substantial differences can be noted. The two devices are intended to be used on Automatic Analyzers: the predicate device with the Roche/Hitachi analyzers, the Sentinel UIBC Liquid on the Abbott AEROSET and ARCHITECT analyzers.

#Design FeatureNew Device Iron LiquidPredicate Device IL Test Iron
1Sample TypeHuman serum and plasma
(only heparin salts)Same
2TechnologyDirect colorimetric without
deproteinizationEnd Point, Colorimetric
3ManufacturerSentinelSame
4InstrumentationAbbott AEROSET and
Abbott ARCHITECT c8000
analyzersIL Lab 600/900/1800 Plus
Chemistry System

Table 7.2 Comparison with Predicate Device

8. Performance Data

Performance evaluations included sensitivity, intra- and inter-assay precision and method comparison.

9. Conclusion

The performance and safety data presented in this premarket notification support a finding of substantial equivalence between the Sentinel Iron Liquid and the predicate devices specified in this submission.

Sentinel Iron Liquid

Image /page/1/Picture/18 description: The image shows the logo for Sentinel Diagnostics. The logo has the word "SENTINEL" in large, stylized font on the top line. Below that, in a smaller font, is the word "DIAGNOSTICS". To the right of the words is a black graphic that looks like a mountain range.

2

DEPARTMENT OF HEALTH & HUMAN SERVICES

Image /page/2/Picture/1 description: The image shows the logo for the Department of Health & Human Services - USA. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is a stylized image of three human profiles facing to the right, with three curved lines above them.

Public Health Service

AUG 25 2005

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

Mr. Davide Spada Application Specialist Sentinel CH Srl Via Principe Eugenio 5 Milan 20155 Italy

Re: K051115

Trade/Device Name: Sentinel Iron Liquid Regulation Number: 21 CFR 862.1410 Regulation Name: Iron (non-heme) test system Regulatory Class: Class I, reserved Product Code: JIY Dated: July 13, 2005 Received: August 8, 2005

Dear Mr. Spada:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in Title 21, Code of Federal Regulations (CFR), Parts 800 to 895. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Parts 801 and 809); and good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820).

3

Page 2 -

This letter will allow you to begin marketing your device as described in your Section 510(k) ruls letter will anow you to ought messing of substantial equivalence of your device to a legally premarked predication: "The PDs in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific information about the application of labeling requirements to your device, or questions on the promotion and advertising of your device, please contact the Office of In Vitro Diagnostic Device Evaluation and Safety at (240) 276-0484. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the I va may ovania of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.

Sincerely yours,

Carol C. Benson

Carol C. Benson, M.A. Acting Director Division of Chemistry and Toxicology Office of In Vitro Diagnostic Device Evaluation and Safety Center for Devices and Radiological Health

Enclosure

4

510(k) Number (if known):K051115
------------------------------------

Sentinel Iron Liquid Device Name: _________________________________________________________________________________________________________________________________________________________________

Indications For Use:

The Sentinel Iron Liquid is a direct colorimetric in vitro diagnostic assay for the quantitative determination of Iron without deproteinization in human serum and plasma (heparin salts, only).

Iron (non-heme) measurements are used in the diagnosis and treatment of diseases such as iron deficiency anemia, hemochromatosis (a disease associated with widespread deposit in the tissues of two iron-containing pigments, hemosiderin and hemofuscin, and characterized by pigmentation of the skin), and chronic renal disease.

Prescription Use (Part 21 CFR 801 Subpart D)

AND/OR

Over-The-Counter Use (21 CFR 801 Subpart C)

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of In Vitro Diagnostic Devices (OIVD)

CAC

Division Sign-Off

Office of In Vitro Diagnostic Device Evaluation and Safety

510(k) K051115

Page 1 of 1___________________________________________________________________________________________________________________________________________________________________